These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 22010782

  • 1. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E, Koksal C, Karasulu E.
    Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
    [Abstract] [Full Text] [Related]

  • 2. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G.
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T.
    Int J Pharm; 2011 May 16; 409(1-2):75-80. PubMed ID: 21371541
    [Abstract] [Full Text] [Related]

  • 4. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S, Agrawal GP.
    Curr Drug Deliv; 2008 Jan 16; 5(1):1-6. PubMed ID: 18220545
    [Abstract] [Full Text] [Related]

  • 5. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib.
    Singh I, Aboul-Enein HY.
    Pharmazie; 2007 Apr 16; 62(4):284-6. PubMed ID: 17484284
    [Abstract] [Full Text] [Related]

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 16; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA, Obaidat RM.
    Acta Pharm; 2011 Mar 16; 61(1):83-91. PubMed ID: 21406346
    [Abstract] [Full Text] [Related]

  • 8. Impact of different organic acids on solubility enhancement of cefpodxime proxetil immediate release tablet and its stability studies.
    Jabeen S, Hassan F, Yousuf RI, Shoaib MH, Israr F, Hasan SMF, Saeed R, Farooqi S.
    Pak J Pharm Sci; 2017 May 16; 30(3):855-866. PubMed ID: 28653931
    [Abstract] [Full Text] [Related]

  • 9. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 16; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 10. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME, Zornoza A, Goñi Mdel M, Isasi JR, Vélaz I, Martín C, Sánchez M, Martínez-Ohárriz MC.
    Drug Dev Ind Pharm; 2009 Oct 16; 35(10):1264-70. PubMed ID: 19555243
    [Abstract] [Full Text] [Related]

  • 11. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M, Bećirević-Laćan M.
    Eur J Pharm Sci; 2004 Feb 16; 21(2-3):251-60. PubMed ID: 14757497
    [Abstract] [Full Text] [Related]

  • 12. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets.
    Fridriksdóttir H, Loftsson T, Gudmundsson JA, Bjarnason GJ, Kjeld M, Thorsteinsson T.
    Pharmazie; 1996 Jan 16; 51(1):39-42. PubMed ID: 8999433
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F, Ozcan I, Guneri T.
    Drug Deliv; 2010 Apr 16; 17(3):152-7. PubMed ID: 20148713
    [Abstract] [Full Text] [Related]

  • 14. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
    Lin HS, Leong WW, Yang JA, Lee P, Chan SY, Ho PC.
    Int J Pharm; 2007 Aug 16; 341(1-2):238-45. PubMed ID: 17482391
    [Abstract] [Full Text] [Related]

  • 15. Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy.
    Yang X, Ke W, Zi P, Liu F, Yu L.
    J Pharm Sci; 2008 Jul 16; 97(7):2702-19. PubMed ID: 17918724
    [Abstract] [Full Text] [Related]

  • 16. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C, Papademou H, Vertzoni M, Archontaki H, Valsami G.
    J Pharm Pharmacol; 2008 Nov 16; 60(11):1433-9. PubMed ID: 18957163
    [Abstract] [Full Text] [Related]

  • 17. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
    Cetin EO, Ilem D, Gundogdu E, Asikoglu M, Kirilmaz L.
    Pharmazie; 2011 Sep 16; 66(9):672-6. PubMed ID: 22026122
    [Abstract] [Full Text] [Related]

  • 18. Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery.
    Cho HJ, Balakrishnan P, Shim WS, Chung SJ, Shim CK, Kim DD.
    Int J Pharm; 2010 Nov 15; 400(1-2):59-65. PubMed ID: 20801202
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W.
    Arch Pharm Res; 2007 Aug 15; 30(8):991-1001. PubMed ID: 17879753
    [Abstract] [Full Text] [Related]

  • 20. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B, Zhong S, Li N, Li X, Yi J, Jin M.
    Drug Dev Ind Pharm; 2013 Nov 15; 39(11):1638-43. PubMed ID: 24087855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.